STAT roundup highlights obesity drug competition and other ADA conference updates
STAT's ADA in 30 Seconds newsletter offers a brief snapshot of the American Diabetes Association's annual meeting, covering a range of topics for readers.
Elaine Chen notes that the market for obesity medicines is becoming increasingly crowded, and she points out several clinical blind spots that remain unaddressed.
Elizabeth Cooney adds updates on eating‑disorder research, new data about a BCG vaccine, and clarifies the ADA's response to a recent police incident at the conference.
The edition is available to STAT+ subscribers and includes links to deeper analysis, alerts, and related premium content.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA”
read at STAT ↗
comments(0)
5-min edit window · permanent after that